Keyphrases
Pancreatic Neuroendocrine Tumors (pNETs)
100%
Von Hippel-Lindau Disease
74%
Multiple Endocrine Neoplasia Type 1 (MEN1)
56%
Rotenone Model
37%
Parkinson's Disease
37%
Catecholamine Biosynthesis
37%
Pheochromocytoma
33%
3,4-Dihydroxyphenylacetaldehyde
32%
Paraganglioma
30%
Catecholaldehyde
28%
Peptide Receptor Radionuclide Therapy
28%
Germ Cells
27%
Working Diagnosis
26%
Primary Hyperparathyroidism (pHPT)
24%
Pituitary Adenoma
23%
Neurochemicals
23%
Diagnostic Criteria
23%
Hemangioblastoma
23%
Patient Characteristics
22%
Rotenone
21%
Partial Response
20%
Free Hemoglobin
18%
International Criteria
18%
Locomotor
18%
Red Cell Mass
18%
Model Relevance
18%
Metastatic Thymoma
18%
Unique Characteristics
18%
Prognostic Marker
18%
Prognostic Factors
18%
CDKN1B
18%
Abnormal Pattern
18%
Normetanephrine
18%
Epigenetic Regulation
18%
Serum Phosphorus
18%
Hypopituitarism
18%
177Lu-DOTATATE
18%
Long-run Risk
18%
Interventional Management
18%
Non-interventional
18%
Ubiquitin-specific Protease 8
18%
Corticotroph Adenoma
18%
Immune Landscape
18%
Advanced Neuroendocrine Tumors
18%
Treatment Response
18%
Lutetium-177 (177Lu)
18%
DOTATATE
18%
Overall Outcome
18%
Epidemiology
18%
Dopamine
15%
Medicine and Dentistry
Pancreas Islet Cell Tumor
79%
Von Hippel-Lindau Disease
56%
Neuroendocrine Tumor
54%
Diseases
49%
Multiple Endocrine Neoplasia Type I
37%
Pituitary Adenoma
34%
Pheochromocytoma
33%
Paraganglioma
30%
Germ Cell
28%
Peptide Receptor
28%
Radionuclide Therapy
28%
Hemangioblastoma
27%
Primary Hyperparathyroidism
24%
CDKN1B
18%
Erythrocyte
18%
Multiple Endocrine Neoplasia
18%
Lutetium 177
18%
Prognostic Factor
18%
Hypopituitarism
18%
Normetanephrine
18%
Deubiquitinase
18%
Catecholamine Synthesis
18%
Somatics
18%
Acromegaly
18%
Lutetium
18%
Suprofen
18%
Treatment Response
18%
Thymus Cancer
18%
Cohort Effect
18%
Neoplasm
17%
Clear Cell Renal Cell Carcinoma
16%
Family History
14%
All Cause Mortality
14%
Hematocrit
13%
Metanephrine
12%
Disease Exacerbation
11%
Intestine Injury
11%
Adenoma
11%
Methylation
10%
Recurrent Disease
9%
Odds Ratio
9%
Central Nervous System
8%
Medical Intervention
8%
Genetic Screening
7%
Hydrocortisone
7%
Autosomal Dominant Inheritance
7%
Secretion (Process)
7%
Polycyclic Aromatic Hydrocarbon
7%
Penetrance
6%
Malignant Neoplasm
6%